📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes. (2024)

First Author: Hobbs FR

Attributed to: Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2024.106248

PubMed Identifier: 39216829

Publication URI: http://europepmc.org/abstract/MED/39216829

Type: Journal Article/Review

Volume: 89

Parent Publication: The Journal of infection

Issue: 4

ISSN: 0163-4453